|
HES1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.920100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.686200E-02 |
| Normal-vs-Stage2 |
2.940900E-03 |
| Normal-vs-Stage3 |
6.498000E-01 |
| Normal-vs-Stage4 |
7.988000E-01 |
| Stage1-vs-Stage2 |
3.130100E-02 |
| Stage1-vs-Stage3 |
1.054390E-01 |
| Stage1-vs-Stage4 |
6.380500E-02 |
| Stage2-vs-Stage3 |
4.262900E-03 |
| Stage2-vs-Stage4 |
3.183400E-03 |
| Stage3-vs-Stage4 |
8.228800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.401800E-01 |
| Normal-vs-AfricanAmerican |
5.194000E-01 |
| Normal-vs-Asian |
4.533000E-01 |
| Caucasian-vs-AfricanAmerican |
8.760000E-01 |
| Caucasian-vs-Asian |
7.017600E-01 |
| AfricanAmerican-vs-Asian |
9.393400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.661700E-02 |
| Normal-vs-Female |
1.630050E-01 |
| Male-vs-Female |
3.090400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.858620E-01 |
| Normal-vs-Age(41-60Yrs) |
1.236230E-01 |
| Normal-vs-Age(61-80Yrs) |
9.244000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.571800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.830600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.194200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.515800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.733400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.736000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.911200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.956300E-03 |
| Classical-VS-Follicular |
1.18079990230058E-10 |
| Classical-VS-Other |
1.489370E-01 |
| Classical-VS-Normal |
7.209400E-01 |
| Tall-VS-Follicular |
1.99118499466522E-12 |
| Tall-VS-Other |
7.710500E-02 |
| Tall-VS-Normal |
1.644570E-01 |
| Follicular-VS-Other |
2.695200E-01 |
| Follicular-VS-Normal |
4.358100003099E-08 |
| Other-VS-Normal |
1.423030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.838400E-03 |
| Normal-vs-N1 |
3.650200E-01 |
| N0-vs-N1 |
4.883800E-02 |
|
|
